Sarkis-Kechiche J
Wien Med Wochenschr. 1980 Jul 31;130(13-14):489-91.
Eleven female chronic Salmonella carriers were treated with the chemotherapeutic drug Co-soltrim for an average period of 19.83 weeks. The daily dose was at first twice 2 tablets and later on twice 1 tablet. Before this treatment 4 of the patients had received other chemotherapeutic drugs without lasting curative effect. The cases were in-patients of a mental hospital and it was possible to continue their observation for a follow-up period of up to 29 months after the termination of the therapy. No case relapsed. The therapy did not produce any undesirable side effects.